Aerosolized ACE2 neutralizes COVID-19 variants in lab and mi

Researchers from the University of Texas Southwestern have developed an aerosolized, mutated form of ACE2 that effectively neutralizes various SARS-CoV-2 variants in both cell cultures and mice. The study suggests that this modified ACE2 has promising preventive and therapeutic potential against COVID-19, especially with its easy aerosolized administration.

Related Keywords

United States , Susha Cheriyedath , University Of Texas Southwestern , Texas Southwestern , Ace2 , Coronavirus Disease Covid 19 , Ngiotensin , Ngiotensin Converting Enzyme 2 , Fell , Coronavirus , Drug Discovery , Efficacy , Nzyme , Immune System , N Vitro , N Vivo , Lentivirus , Utation , Protein , Eceptor , Research , Espiratory , Cars , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome , Virus ,